Education

Timely Topics in Transplantation Webinar Series

November 10, 2021

VIEW ON-DEMAND

After participating in this webinar, the attendee will be able to:

  1. Discuss the importance of preventing physician burnout and suicide.
  2. Examine lessons learned from the front line of physician burnout and suicide.
  3. Discuss next steps in protecting physician well-being to prevent negative mental health outcomes .

Speakers:

  • Katherine Twombley, MD, FAAP, FAST • Professor of Pediatrics, Medical University of South Carolina, Charleston, SC
  • Michelle Jesse, MD, FAST • Clinical Health Psychologist, Henry Ford Health System, Detroit, MI

Moderator:

  • Marwan Abouljoud, MD, FACS, CPE, MMM • Benson Ford Endowed Chair, Director, Henry Ford Transplant Institute, Detroit, MI
---

AST would like to thank the Pediatrics Community of Practice (PCOP) for recommending this topic to include as part of the T3 webinar series, and the Psychosocial and Ethics Community of Practice (PSECOP) for providing additional planning and support for the session. Learn more about AST's COPs at www.myast.org/cops.

October 27, 2021

VIEW ON-DEMAND

After participating in this webinar, the attendee will be able to:

  1. Understand the risk factors for and impact of multidrug-resistant organisms on transplant recipients.
  2. Review novel therapeutics for multidrug-resistant organism infections in transplant recipients.
  3. Understand antimicrobial stewardship concepts and their importance in solid organ transplantation.
  4. Describe the current state of antimicrobial stewardship in solid organ transplantation and identify implementation opportunities.

Speakers:

  • Judith Anesi, MD, MSCE • Assistant Professor of Medicine and Epidemiology, University of Pennsylvania, Philadelphia, PA
  • Jonathan Hand, MD, FIDSA, FAST • Medical Director, Transplant Infectious Diseases, Ochsner Health, New Orleans, LA

Moderator:

  • Stephanie Pouch, MD, MS, FAST • Associate Professor of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA
- - - - -

AST would like to thank the Infectious Disease Community of Practice (IDCOP) for recommending this topic to include as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.

September 29, 2021

VIEW ON-DEMAND

After participating in this webinar, the attendee will be able to:

  1. Describe the core concepts underlying the disease of addiction.
  2. Understand implications of prescription opioid use, benzodiazepine use, and cannabis use disorder before and after transplant on recipient outcomes, at the population-level.
  3. Identify the implications of prescription opioid use on living donor outcomes, at the population level.
  4. Understand the risks of relapse to substance use disorders and factors that may predict relapse risk.
  5. Discuss current controversies that relate to substance use and transplantation, including marijuana use and transplantation for acute alcoholic hepatitis.

Speakers:

  • Marian Fireman, MD • Professor of Psychiatry, Oregon Health and Science University, Portland, OR
  • Krista Lentine, MD, PhD, FAST • Professor of Medicine, Saint Louis University School of Medicine, Saint Louis, MO

Moderator:

  • Antú Segal, PsyD, ABPP • Senior Staff Clinical Health Psychologist, Henry Ford Hospital; Detroit, MI
- - - - -

AST would like to thank the Living Donor Community of Practice (LDCOP) and Pediatrics Community of Practice (PCOP) for recommending related topics to include as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.

April 22, 2021

View Archive

After participating in this webinar, the attendee will be able to:

  1. Be knowledgeable of background data regarding hepatitis C (HCV) in solid organ transplant
  2. Describe relevant considerations in the assessment of potential living donors with active or prior HCV infection which may impact donor and recipient outcomes
  3. Appreciate a framework for the screening and evaluation of such donors
  4. Describe waitlist management and ethical considerations

Speakers:

  • Cameron Wolfe, MD, MBBS(Hons), MPH, FIDSA • Associate Professor of Medicine, Infectious Disease, Duke University Medical Center, Durham, NC
  • Whitney Jackson, MD • Assistant Professor, Medicine-Gastroenterology, University of Colorado Medicine, Aurora, CO
  • Roy Bloom, MD • Professor of Medicine, University of Pennsylvania Hospital, Philadelphia, PA

Moderator:

  • AnnMarie Liapakis, MD • Associate Professor of Medicine, Medical Director Living Donor Liver Transplant, Yale New Haven Transplantation Center, New Haven, CT
- - - - -

AST would like to thank the Live Donor Community of Practice (LDCOP) and the Liver and Intestinal Community of Practice (LICOP) for recommending this topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

April 14, 2021

View Archive

After participating in this webinar, the attendee will be able to:

  1. Describe the evolving role of machine perfusion in the evaluation and preservation of cardiothoracic organs.
  2. Describe the evolving role of machine perfusion in the evaluation and preservation of abdominal organs.
  3. Describe the evolving role of the Organ Procurement Organization (OPO) in the coordination of the logistics involved in the use of machine perfusion.
  4. Understand at a high level who pumps, who pays, and who benefits.

Speakers:

  • Kevin Myer, MSHA • President and Chief Executive Officer, LifeGift, Houston, TX
  • Jorge Mallea, MD • Consultant, Division of Pulmonary, Allergy, and Sleep Medicine, Mayo Clinic Florida, Jacksonville, FL

Moderator:

  • Malcolm MacConmara, MD, MB BCh, FACS • Assistant Professor, University of Texas Southwestern Medical Center, Dallas, TX
- - - - -

AST would like to thank the Recovery and Preservation Community of Practice (RAP COP) for recommending "Perfusion Technologies" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

May 05, 2021

View Archive

After participating in this webinar, the attendee will be able to:

  1. Explain the evolution of pharmacy and advanced practice providers in solid organ transplant.
  2. Share current inpatient multidisciplinary practice models.
  3. Describe the various roles of pharmacists and advanced practice providers in the outpatient setting.
  4. Discuss future opportunities for transplant pharmacists and advanced practice providers.

Speakers:

  • Holli Winters, PharmD, BCPS • Specialty Practice Pharmacist, Solid Organ Transplantation, The Ohio State Wexner Medical Center, Columbus, OH
  • Gina Jamero, MSN, ACNP-BC • Lead Nurse Practitioner, Heart Transplant and Mechanical Circulatory Support Cardiology, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

Moderator:

  • Anna Frank, PA-C • Lead Advanced Practice Provider, MedStar Georgetown Transplant Institute, Washington, D.C.
- - - - -

AST would like to thank the Advanced Practice Provider Community of Practice (APP COP) and the Transplant Pharmacy Community of Practice (TxPharm COP) for recommending this topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops. The session title has been updated from "Integrated Multi-discipline Model Across the Care Continuum: A Focus on Advance Care Practice Provider- and Pharmacist-driven Service Lines" to better reflect the focus of the presentation.

March 24, 2021

View Archive

After participating in this webinar, the attendee will be able to:

  1. Educate the transplant community on the current understanding of frailty both pre and post solid organ transplantation.
  2. Establish a standardized approach for the identification and treatment of frailty both pre- and post-transplantation, including:
    A) Establishing a common nomenclature for frailty within solid organ transplantation
    B) Establishing recommendations for the assessment of frailty in solid organ transplant candidates
    C) Establishing guidelines for including a frailty assessment in candidate selection

Speakers:

  • Jennifer Lai, MD, MBA • Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
  • Mara McAdams DeMarco, PhD • Associate Professor of Surgery and Epidemiology, Director of Clinical and Outcomes Research, Johns Hopkins University, Baltimore, MD
  • Evan Kransdorf, MD, PhD • Assistant Director, Heart Transplant Research and Education, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

Moderator:

  • Lianne Singer, MD, FRCPC • Professor of Medicine, University Health Network, University of Toronto, Toronto, ON
- - - - -

AST would like to thank the Women's Health Community of Practice (WHCOP) for recommending "Frailty" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

December 17, 2020

View Archive

For "NanoString Technologies for Intragraft Gene Expression" - after participating in this webinar, the attendee will be able to:

  1. Recognize current methodologies and clinical indications for intragraft gene expression testing.
  2. Describe new opportunities afforded by emerging FFPE-based intragraft gene expression technologies.

For "Donor-Derived Cell-Free DNA" - after participating in this webinar, the attendee will be able to:

  1. Understand the available data on the use of donor-derived cell-free DNA for solid organ transplants (kidney, pancreas, liver, heart, lung).
  2. Understand the limitations and future directions of available data on the use of donor-derived cell-free DNA for solid organ transplants.

For "Urinary Biomarkers" - after participating in this webinar, the attendee will be able to:

  1. Explain the use of urine as a surrogate for kidney allograft biopsy.
  2. Discuss strategies to develop and validate robust biomolecular markers of kidney allograft status.
  3. Describe urinary cell biomolecular markers of human kidney allograft status.

Speakers:

  • Benjamin Adam, MD, FRCPC • Assistant Professor of Pathology, University of Alberta, Edmonton, AB
  • Gaurav Gupta, MD • Associate Professor; Medical Director of Kidney Transplantation, Virginia Commonwealth University, Richmond, VA
  • Manikkam Suthanthiran, MD • Stanton Griffis Distinguished Professor of Medicine - Weill Cornell Medical College, Cornell University, New York, NY

Moderator:

  • Minnie Sarwal, MD, PhD, FRCP, DCH • Professor, Surgery; Director, Kidney-Pancreas Transplant, UCSF, San Francisco, CA
- - - - -

AST would like to thank the Community of Transplant Scientists (COTS) and the Transplant Diagnostics Community of Practice (TxDx COP) for recommending topics related to "gene expression" and "biomarkers" for the 2020-2021 T3 series. These suggestions directly contributed to the creation of the "Biomarkers and gene expression profiling in transplantation" webinar. Learn more about AST's COPs at www.myast.org/cops.

December 09, 2020

View Archive

After participating in this webinar, the attendee will be able to:

  1. Describe the prevalence and impact of non-adherence in the solid organ transplant population.
  2. Review types of technology to optimize transplant education, manage polypharmacy and increase adherence.
  3. Identify technology related barriers, challenges and real-world strategies to improve use in clinical practice.

Speakers:

  • Holly Mansell, PharmD, BSP • Associate Professor of Pharmacy, University of Saskatchewan, Saskatoon, SK
  • Tiffany Kaiser, PharmD, MS, FCCP, BCPS • Associate Professor of Medicine, University of Cincinnati, Cincinnati, OH

Moderator:

  • Patricia West-Thielke, PharmD, BCPS, FAST • Director of Clinical Research, University of Illinois at Chicago, Chicago, IL
- - - - -

AST would like to thank the Transplant Pharmacy Community of Practice (TxPharm COP) for recommending "Use of Technology to Optimize Transplant Education, Manage Polypharmacy, and Increase Adherence" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

January 27, 2021

View Archive

After participating in this webinar, the attendee will be able to:

  1. Identify different types of performance measures.
  2. Define components of performance measures to ensure purposeful and meaningful data.
  3. Describe how to analyze and interpret data to evaluate performance.
  4. Discuss transplant-specific performance measures and how we can use them to improve care.

Speakers:

  • Marian O’Rourke, RN, BSN, CCTC • Director, Quality, Compliance, and Outcomes Management, Miami Transplant Institute, Jackson Memorial Hospital/University of Miami, Miami, FL
  • Jesse Schold, PhD, M Stat, MEd • Director Outcomes Research, Cleveland Clinic, Cleveland, OH

Moderator:

  • Andrea Tietjen, MBA, CPA • Director of Transplant Finance, Quality and Data, Saint Barnabas Medical Center, Livingston, NJ
- - - - -

AST would like to thank the Transplant Administration & Quality Management Community of Practice (TxAQM COP) for recommending "Performance Measures - Ensuring Meaningful Data" as a topic for the 2020-2021 T3 series. Learn more about AST's COPs at www.myast.org/cops.

Pages